Trial
NCT00746486
Ursodeoxycholic Acid Plus Budesonide Versus Ursodeoxycholic Acid Alone in Primary Biliary Cirrhosis (PBC)
Phase IIITERMINATEDSAFETYConfidence: MEDIUM
Sponsor
Dr. Falk Pharma GmbH
Collaborators
—
Condition
Primary Biliary Cirrhosis
Intervention
budesonide
Why stopped
Study stopped based on the recommendation of the IDMC after a planned Interim Analysis
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2020-01-28